Neurochemical correlates of rapid treatment response to electroconvulsive therapy in patients with major depression

Background Electroconvulsive therapy (ECT) is a highly effective brain stimulation treatment for severe depression. Identifying neurochemical changes linked with ECT may point to biomarkers and predictors of successful treatment response. Methods We used proton magnetic resonance spectroscopy (1H-MRS) to measure longitudinal changes in glutamate/glutamine (Glx), creatine (Cre), choline (Cho) and N-acetylaspartate (NAA) in the dorsal (dACC) and subgenual anterior cingulate cortex (sgACC) and bilateral hippocampus in patients receiving ECT scanned at baseline, after the second ECT session and after the ECT treatment series. Patients were compared with demographically similar controls at baseline. Controls were assessed twice to establish normative values and variance. Results We included 50 patients (mean age 43.78 ± 14 yr) and 33 controls (mean age 39.33 ± 12 yr) in our study. Patients underwent a mean of 9 ± 4.1 sessions of ECT. At baseline, patients showed reduced Glx in the sgACC, reduced NAA in the left hippocampus and increased Glx in the left hippocampus relative to controls. ECT was associated with significant increases in Cre in the dACC and sgACC and decreases in NAA in the dACC and right hippocampus. Lower NAA levels in the dACC at baseline predicted reductions in depressive symptoms. Both ECT and symptom improvement were associated with decreased Glx in the left hippocampus and increased Glx in the sgACC. Limitations Attrition and clinical heterogeneity may have masked more subtle findings. Conclusion ECT elicits robust effects on brain chemistry, impacting Cre, NAA and Glx, which suggests restorative and neurotrophic processes. Differential effects of Glx in the sgACC and hippocampus, which approach control values with treatment, may reflect previously implicated underactive cortical and overactive subcortical limbic circuitry in patients with major depression. NAA levels at baseline are predictive of therapeutic outcome and could inform future treatment strategies.

[1]  Shantanu H. Joshi,et al.  Structural Plasticity of the Hippocampus and Amygdala Induced by Electroconvulsive Therapy in Major Depression , 2016, Biological Psychiatry.

[2]  Shantanu H. Joshi,et al.  Denoising of MR spectroscopy signals using total variation and iterative Gauss-Seidel gradient updates , 2015, 2015 IEEE 12th International Symposium on Biomedical Imaging (ISBI).

[3]  M. Trivedi,et al.  Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches. , 2015, The American journal of psychiatry.

[4]  Shantanu H. Joshi,et al.  Electroconvulsive therapy mediates neuroplasticity of white matter microstructure in major depression , 2014, Translational Psychiatry.

[5]  Bruce N Cuthbert,et al.  The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology , 2014, World psychiatry : official journal of the World Psychiatric Association.

[6]  R. Fosse,et al.  Electroconvulsive Treatment: Hypotheses about Mechanisms of Action , 2013, Front. Psychiatry.

[7]  R. Woods,et al.  Glutamate normalization with ECT treatment response in major depression , 2013, Molecular Psychiatry.

[8]  E. Bryson,et al.  ECT in treatment-resistant depression. , 2012, The American journal of psychiatry.

[9]  Amelia J. Eisch,et al.  Depression and Hippocampal Neurogenesis: A Road to Remission? , 2012, Science.

[10]  Bruce Fischl,et al.  Volumetric navigators for prospective motion correction and selective reacquisition in neuroanatomical MRI , 2012, Magnetic resonance in medicine.

[11]  G. Sanacora,et al.  Towards a glutamate hypothesis of depression An emerging frontier of neuropsychopharmacology for mood disorders , 2012, Neuropharmacology.

[12]  G. Venkatasubramanian,et al.  Proton magnetic resonance spectroscopy in depression , 2011, Indian journal of psychiatry.

[13]  A. V. D. van der Kouwe,et al.  Real‐time motion and B0 corrected single voxel spectroscopy using volumetric navigators , 2011, Magnetic resonance in medicine.

[14]  E. Nestler,et al.  Linking molecules to mood: new insight into the biology of depression. , 2010, The American journal of psychiatry.

[15]  M. Yücel,et al.  Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. , 2009, Journal of affective disorders.

[16]  J. Grafman,et al.  Prefrontal asymmetry in depression? The long-term effect of unilateral brain lesions , 2009, Neuroscience Letters.

[17]  Gregers Wegener,et al.  Repeated electroconvulsive seizures increase the total number of synapses in adult male rat hippocampus , 2009, European Neuropsychopharmacology.

[18]  F. Jessen,et al.  Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response. , 2009, The international journal of neuropsychopharmacology.

[19]  E. Gordon,et al.  Improving the Prediction of Treatment Response in Depression: Integration of Clinical, Cognitive, Psychophysiological, Neuroimaging, and Genetic Measures , 2008, CNS Spectrums.

[20]  M. Furey,et al.  Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression , 2008, Brain Structure and Function.

[21]  W. Drevets,et al.  The Subgenual Anterior Cingulate Cortex in Mood Disorders , 2008, CNS Spectrums.

[22]  Abraham Z. Snyder,et al.  Altered Emotional Interference Processing in Affective and Cognitive-Control Brain Circuitry in Major Depression , 2008, Biological Psychiatry.

[23]  Fa-jin Lv,et al.  1H magnetic resonance spectroscopy study of thalamus in treatment resistant depressive patients , 2007, Neuroscience Letters.

[24]  H. Schmidt,et al.  The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior , 2007, Behavioural pharmacology.

[25]  Gregor Hasler,et al.  Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. , 2007, Archives of general psychiatry.

[26]  Matthew S. Grubb,et al.  Adult neurogenesis and functional plasticity in neuronal circuits , 2006, Nature Reviews Neuroscience.

[27]  Gregory G. Brown,et al.  Does amygdalar perfusion correlate with antidepressant response to partial sleep deprivation in major depression? , 2006, Psychiatry Research: Neuroimaging.

[28]  A. Lozano,et al.  Deep Brain Stimulation for Treatment-Resistant Depression , 2005, Neuron.

[29]  Masato Fukuda,et al.  Executive and prefrontal dysfunction in unipolar depression: a review of neuropsychological and imaging evidence , 2004, Neuroscience Research.

[30]  Anthony R. McIntosh,et al.  Limbic–frontal circuitry in major depression: a path modeling metanalysis , 2004, NeuroImage.

[31]  A. Rush,et al.  Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report. , 2004, The Journal of clinical psychiatry.

[32]  Morris H. Baslow,et al.  N-Acetylaspartate in the Vertebrate Brain: Metabolism and Function , 2003, Neurochemical Research.

[33]  V. Arolt,et al.  Neurotrophic Effects of Electroconvulsive Therapy: A Proton Magnetic Resonance Study of the Left Amygdalar Region in Patients with Treatment-Resistant Depression , 2003, Neuropsychopharmacology.

[34]  Martin Fiebich,et al.  Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients , 2003, Psychiatry Research: Neuroimaging.

[35]  H. Mayberg.  Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. , 2003, British medical bulletin.

[36]  A. Rush,et al.  ECT Remission Rates in Psychotic Versus Nonpsychotic Depressed Patients: A Report from CORE , 2001, The journal of ECT.

[37]  H. Sackeim,et al.  Decreased regional brain metabolism after ect. , 2001, The American journal of psychiatry.

[38]  Richard M. Leahy,et al.  BrainSuite: An Automated Cortical Surface Identification Tool , 2000, MICCAI.

[39]  D. Braus,et al.  The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. , 2000, Archives of general psychiatry.

[40]  Bernadette Lipinski,et al.  Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study , 2000, Biological Psychiatry.

[41]  L. Parsons,et al.  Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. , 1999, The American journal of psychiatry.

[42]  T. J. Harrison.  The Human Central Nervous System. A Synopsis and Atlas. , 1979 .

[43]  C. Clayman,et al.  The Human Central Nervous System: A Synopsis and Atlas , 1979 .

[44]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[45]  M. Hamilton.  A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[46]  S. Lui,et al.  Is depression a disconnection syndrome? Meta-analysis of diffusion tensor imaging studies in patients with MDD. , 2013, Journal of psychiatry & neuroscience : JPN.

[47]  J. Price,et al.  Neurocircuitry of Mood Disorders , 2010, Neuropsychopharmacology.

[48]  Jürgen R. Reichenbach,et al.  Absolute quantitation of brain metabolites with respect to the CSF fraction in 1H-MR spectroscopic volumes , 2009 .

[49]  Camellia P. Clark,et al.  Sleep deprivation as a model experimental antidepressant treatment: Findings from functional brain imaging , 2001, Depression and anxiety.